Kubisa Bartosz, Piotrowska Maria, Milczewska Justyna, Bielewicz Michał, Pieróg Jarosław, Kozak Anna, Czarnecka Michalina, Wójcik Norbert, Wasilewski Piotr, Feledyk Grzegorz, Kubisa Anna, Brykczyński Mirosław, Sielicki Piotr, Grodzki Tomasz
Thoracic Surgery and Transplantation Department,Pomeranian Medical University of Szczecin, Alfreda Sokołowskiego Street 11, 70-891 Szczecin-Zdunowo, Poland, e-mail:
Dev Period Med. 2015 Jan-Mar;19(1):120-6.
The surgeon's viewpoint on a patient with cystic fibrosis differs from that of a pediatrician or internist. The problems a cystic fibrosis specialist encounters are different from those faced by the surgeon who takes over the patient in a very advanced, often terminal stage of the disease. Hence, the main problem for the surgeon is the decision concerning the surgery (lung transplantation, pneumonectomy, lobectomy). It is, therefore, important to lay down fundamental and appropriate rules concerning the indications and contraindications for lung transplantation, especially in patients with cystic fibrosis.
The aim of this study was to analyze the methods of qualifying and preparing patients for surgery, as well as carrying out the procedure of transplantation and postoperative short and long-term care.
The investigation was carried out on 16 patients with cystic fibrosis. Three were operated on and 10 were on the waiting list for transplantation. Two patients on the waiting list died, one patient was disqualified from transplantation. During qualification for lung transplantation, strict indications, contraindications and other factors (such as blood type, patient's height, coexisting complications) were taken under consideration.
All the 3 patients after lung transplantation are alive and under our constant surveillance. Ten patients await transplantation, though four of them are suspended due to hepatitis C infection. Two patients on the waiting list died: one from respiratory insufficiency and the other in the course of bridge to-transplant veno-venous extracorporeal membrane oxygenation due to hepatic failure. One patient has been disqualified because of cachexia.
Since lung transplantation is the final treatment of the end-stage pulmonary insufficiency in cystic fibrosis patients, the number of such procedures in cystic fibrosis is still too low in Poland. The fast development of these procedures is highly needed. It is necessary to develop better cooperation between different disciplines and specialists, especially between pediatricians and surgeons. The correct choice of the suitable moment for lung transplantation is crucial for the success of the procedure.
外科医生对囊性纤维化患者的看法与儿科医生或内科医生不同。囊性纤维化专科医生遇到的问题与接手处于疾病非常晚期、通常是终末期患者的外科医生所面临的问题不同。因此,外科医生面临的主要问题是关于手术(肺移植、肺切除术、肺叶切除术)的决策。所以,制定关于肺移植适应症和禁忌症的基本且恰当的规则非常重要,尤其是对于囊性纤维化患者。
本研究的目的是分析患者手术资格认定和准备方法,以及进行移植手术及术后短期和长期护理的过程。
对16例囊性纤维化患者进行了调查。3例接受了手术,10例在等待移植名单上。等待名单上的2例患者死亡,1例患者被取消移植资格。在肺移植资格认定过程中,考虑了严格的适应症、禁忌症和其他因素(如血型、患者身高、并存并发症)。
所有3例肺移植患者均存活并处于我们的持续监测之下。10例患者等待移植,不过其中4例因丙型肝炎感染而暂停。等待名单上的2例患者死亡:1例死于呼吸功能不全,另1例在桥接至移植的静脉 - 静脉体外膜肺氧合过程中因肝功能衰竭死亡。1例患者因恶病质被取消资格。
由于肺移植是囊性纤维化患者终末期肺功能不全的最终治疗方法,在波兰,此类手术的数量仍然过低。迫切需要这些手术的快速发展。不同学科和专家之间,尤其是儿科医生和外科医生之间,有必要开展更好的合作。正确选择合适的肺移植时机对手术成功至关重要。